Sinopharm Ghana Limited, a leading pharmaceutical company in the country has launched a new product known as Artesunate for Injection into Ghana’s competitive pharmaceutical industry.
The Marketing Manager of the company, Mr. Daniel Djameh, who performed the launch in Accra, said, “Artesunate Injection is the preferred choice in the initial treatment of malaria.”
He noted that the treatment objective of Artesunate for Injection was able to prevent patients from dying, and was water soluble, as well as clearing mosquito parasite, fever and coma recovery.
Mr. Djameh appealed to people to purchase the product, so to reduce the number of malaria deaths in the country.
Source: The Chronicle
|Disclaimer: Opinions expressed here are those of the writers and do not reflect those of Peacefmonline.com. Peacefmonline.com accepts no responsibility legal or otherwise for their accuracy of content. Please report any inappropriate content to us, and we will evaluate it as a matter of priority.|